.png)
Precision Targeting in Rare Disease: Why Lab Data is the "Early Warning System" Pharma Needs
We are living in an era of unprecedented rare disease advocacy. Medical parents and patient groups...
The Data Quality Illusion: Why Aggregated EHR Feeds Often Fail
In the life sciences industry, "lab data" is often treated as a commodity. The assumption is that a...
Tracking the Shift: Real-World Adoption of Emerging IHC Markers in Early 2026
Moving beyond the "hype" to seeing actual testing adoption on the ground.
The New Precision Oncology Battleground: Tracking FOLR1, CLDN18.2, and cMET
As Antibody-Drug Conjugates (ADCs) reshape the therapeutic landscape, commercial success depends on...
Beyond the Centers of Excellence: Maximizing ROI and Finding the Missing Rare Disease Patient Cohort
The pursuit of patients with rare diseases is a critical but notoriously challenging endeavor for...
Case Study: Optimizing Patient Identification in Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes (MDS) are a group of bone marrow disorders characterized by ineffective...
Driving Commercial Strategy in ALL: The Critical Role of Lab Data
For pharmaceutical commercial teams, understanding the full patient journey is critical. In the...
%20(1).png)
7 Best Practices for Lab Data Licensing: Maximize Value in Oncology & Genomics
By Jason Bhan, MD, Bill Paquin, Chris Hayes, Sundeep Bhan, Michael Cheyne [Bonus: Link to the free...
Shining a Light on Colorectal Cancer Awareness Month
Shining a Light on Colorectal Cancer Awareness Month March is Colorectal Cancer Awareness Month, a...
Keeping the Focus on Kidney Health: Beyond World Kidney Day and the Nuances of CKD
World Kidney Day, observed yesterday on March 13, served as a powerful reminder of the critical...